https://www.live-feeds.com/feed/scientists-may-have-solved-weight-regain-problem-from-glp-1-drugsContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/scientists-may-have-solved-weight-regain-problem-from-glp-1-drugshttps://www.live-feeds.com/feed/scientists-may-have-solved-weight-regain-problem-from-glp-1-drugs#u15513Sat, 27 Jun 2026 08:07:12 +0000Most patients experience rapid weight regain and metabolic reversal after stopping GLP-1 medications. This trend often leads patients with type 2 diabetes to restart treatment. Drug development is now shifting focus toward sustainable benefits and medication persistence.What's confirmed:Most patients experience rapid weight regain and metabolic reversal after stopping semaglutide.Research indicates 50-80% of GLP-1 users regain weight after stopping treatment.Many GLP-1 users with type 2 diabetes who stop treatment eventually restart because of weight regain.Obesity drug development is moving t https://www.live-feeds.com/feed/scientists-may-have-solved-weight-regain-problem-from-glp-1-drugshttps://www.live-feeds.com/feed/scientists-may-have-solved-weight-regain-problem-from-glp-1-drugs#u10354Tue, 23 Jun 2026 21:56:09 +0000New research suggests a procedure can reset healthy tissue to a lower body weight to prevent regain. Current data shows most patients regain significant weight after stopping GLP-1 medications. Many users follow a pattern of stopping and restarting these drugs.What's confirmed:More than half of patients who stop weight-loss drugs restart within a year.Many patients exhibit stop-and-start patterns with GLP-1 medications.Still unconfirmed:Between 50-70% of people regain weight after stopping Mounjaro.